---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-26-009155"
form_type: "8-K"
ticker: "CURX"
cik: "0002025942"
company_name: "Curanex Pharmaceuticals Inc"
filed_at: "2026-03-06T23:59:59+00:00"
generated_at: "2026-05-15T19:03:33.146560+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.5
calibrated_materiality_score: 0.5
confidence: "high"
source: SEC EDGAR
---

# Curanex Pharmaceuticals formalizes CEO/COO agreements; base salaries $393,600 and $180,000

## Summary
- CEO Jun Liu: annual base salary $393,600, three-year term, plus $3,998/month auto lease.
- COO Dr. Liqin Xie: annual salary $180,000, at-will employment, three-month severance on without-cause termination.
- CEO served without compensation from Feb 2024 to Aug 2025; received $325,000.08 for past services through March 1, 2026.
- Both agreements include 18-month non-compete (CEO), non-solicitation, and clawback provisions under policy effective Aug 12, 2025.
- Termination without cause or for good reason triggers 3 months' salary continuation and immediate equity vesting for both.

## SEC filing metadata
- accession: 0001493152-26-009155
- form_type: 8-K
- ticker: CURX
- cik: 0002025942
- company_name: Curanex Pharmaceuticals Inc
- filed_at: 2026-03-06T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.5
- calibrated_materiality_score: 0.5
- confidence: high
- sec_items: 1.01, 5.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/2025942/000149315226009155/0001493152-26-009155-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/2025942/000149315226009155/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-26-009155
- JSON: https://secwatch.observer/filing/0001493152-26-009155.json
- Plain text: https://secwatch.observer/filing/0001493152-26-009155.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.